Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico.
Company profile
Ticker
CANOQ
Exchange
Website
CEO
Marlow Hernandez Cano
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Jaws Acquisition Corp.
SEC CIK
Corporate docs
Subsidiaries
Primary Care (ITC) Intermediate Holdings, LLC • Cano Health, LLC • Complete Medical Billing and Coding Services, LLC • Cano Pharmacy, LLC • Comfort Pharmacy 2, LLC • Physicians Partners Group • Cano Health of Florida, LLC • University Healthcare Pharmacy, LLC • DGM MSO, LLC • Cano Medical Center of West Florida, LLC ...
CANOQ stock data
Latest filings (excl ownership)
8-K
Regulation FD Disclosure
22 Apr 24
8-K
Other Events
11 Apr 24
10-K
2023 FY
Annual report
1 Apr 24
EFFECT
Notice of effectiveness
1 Apr 24
EFFECT
Notice of effectiveness
1 Apr 24
EFFECT
Notice of effectiveness
1 Apr 24
EFFECT
Notice of effectiveness
1 Apr 24
EFFECT
Notice of effectiveness
1 Apr 24
EFFECT
Notice of effectiveness
1 Apr 24
8-K
Regulation FD Disclosure
25 Mar 24
Transcripts
CANOQ
Earnings call transcript
2023 Q3
9 Nov 23
CANOQ
Earnings call transcript
2023 Q2
10 Aug 23
CANOQ
Earnings call transcript
2023 Q2
10 Aug 23
CANOQ
Earnings call transcript
2023 Q1
9 May 23
CANOQ
Earnings call transcript
2022 Q4
1 Mar 23
CANOQ
Earnings call transcript
2022 Q3
10 Nov 22
CANOQ
Earnings call transcript
2022 Q2
10 Aug 22
CANOQ
Earnings call transcript
2022 Q1
9 May 22
CANOQ
Earnings call transcript
2021 Q3
9 Nov 21
CANOQ
Earnings call transcript
2021 Q2
13 Aug 21
Latest ownership filings
SC 13D/A
MSP Recovery, Inc.
4 Apr 24
4
MSP Recovery, Inc.
3 Apr 24
4
MSP Recovery, Inc.
29 Mar 24
SC 13D/A
MSP Recovery, Inc.
26 Mar 24
4
MSP Recovery, Inc.
26 Mar 24
4
MSP Recovery, Inc.
21 Mar 24
SC 13D/A
MSP Recovery, Inc.
18 Mar 24
4
MSP Recovery, Inc.
18 Mar 24
4
MSP Recovery, Inc.
13 Mar 24
SC 13D/A
MSP Recovery, Inc.
11 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 41.33 mm | 41.33 mm | 41.33 mm | 41.33 mm | 41.33 mm | 41.33 mm |
Cash burn (monthly) | (no burn) | (no burn) | 163.95 mm | 98.97 mm | 13.24 mm | 12.24 mm |
Cash used (since last report) | n/a | n/a | 1.14 bn | 686.81 mm | 91.86 mm | 84.92 mm |
Cash remaining | n/a | n/a | -1.10 bn | -645.48 mm | -50.53 mm | -43.59 mm |
Runway (months of cash) | n/a | n/a | -6.7 | -6.5 | -3.8 | -3.6 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 140 |
Opened positions | 19 |
Closed positions | 39 |
Increased positions | 39 |
Reduced positions | 41 |
13F shares | Current |
---|---|
Total value | 23.76 bn |
Total shares | 133.84 mm |
Total puts | 291.60 k |
Total calls | 4.10 mm |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Marlow Hernandez | 22.03 mm | $0.00 |
Vanguard | 18.57 mm | $4.71 bn |
BLK Blackrock | 15.48 mm | $3.92 bn |
D. E. Shaw & Co. | 11.07 mm | $2.81 bn |
Diameter Capital Partners | 9.82 mm | $3.02 mm |
Owl Creek Asset Management | 9.63 mm | $2.44 bn |
Integrated Core Strategies | 6.28 mm | $55.99 mm |
Geode Capital Management | 4.62 mm | $1.17 bn |
STT State Street | 4.46 mm | $1.13 bn |
Camber Capital Management | 4.00 mm | $1.01 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Apr 24 | Cano Health | Class A Common Stock | Sell | Dispose S | Yes | No | 0.88 | 1,109,500 | 976.36 k | 903,655 |
1 Apr 24 | Cano Health | Class A Common Stock | Sell | Dispose S | Yes | No | 0.67 | 30,376 | 20.35 k | 2,013,155 |
28 Mar 24 | Cano Health | Class A Common Stock | Sell | Dispose S | Yes | No | 0.69 | 25,778 | 17.79 k | 2,043,531 |
27 Mar 24 | Cano Health | Class A Common Stock | Sell | Dispose S | Yes | No | 0.7 | 24,935 | 17.45 k | 2,069,309 |
26 Mar 24 | Cano Health | Class A Common Stock | Sell | Dispose S | Yes | No | 0.73 | 20,000 | 14.60 k | 2,094,244 |
25 Mar 24 | Cano Health | Class A Common Stock | Sell | Dispose S | Yes | No | 0.74 | 23,600 | 17.46 k | 2,114,244 |
22 Mar 24 | Cano Health | Class A Common Stock | Sell | Dispose S | Yes | No | 0.75 | 52,502 | 39.38 k | 2,137,844 |
21 Mar 24 | Cano Health | Class A Common Stock | Sell | Dispose S | Yes | No | 0.75 | 43,711 | 32.78 k | 2,190,346 |
20 Mar 24 | Cano Health | Class A Common Stock | Sell | Dispose S | Yes | No | 0.76 | 46,246 | 35.15 k | 2,234,057 |
19 Mar 24 | Cano Health | Class A Common Stock | Sell | Dispose S | Yes | No | 0.77 | 28,057 | 21.60 k | 2,280,303 |
Press releases
NYSE Suspends Trading in Cano Health, Inc. (CANO) and Commences Delisting Proceedings
5 Feb 24
Thinking about buying stock in Cano Health, Vaxart, Macy's, Albemarle Corp, or BioXcel Therapeutics?
5 Feb 24
Cano Health Enters Restructuring Support Agreement with a Significant Majority of its Lenders to Strengthen Financial Position
4 Feb 24